Treating a common heart rhythm disorder by burning heart tissue with a catheter works dramatically better than drug treatments, a major international study has found. One year after undergoing a treatment called catheter ablation, 63 percent of patients with an irregular heartbeat called atrial fibrillation...
Heating Heart With Catheter Better Than Drugs For Common Heart Rhythm Disorder
Study Shows Relationship Between Atrial Fibrillation And Development Of Alzheimer’s Disease
Researchers at Intermountain Medical Center in Salt Lake City believe that they have made a breakthrough connection between atrial fibrillation, a fairly common heart rhythm disorder, and Alzheimer’s disease, the leading form of dementia among Americans. In a study presented May 15, at “Heart...
Clinical Data, Inc. Expands FAMILION(R) Long QT Syndrome Test By Doubling The Number Of Genes
PGxHealth, a division of Clinical Data, Inc. (NASDAQ: CLDA), a biotechnology company developing targeted therapeutics and genetic and pharmacogenomic tests to detect diseases and predict drug safety, tolerability and efficacy, announced at the Heart Rhythm Society meeting that it will double the number...
St. Jude Medical Announces European Approval Of Accent RF And Anthem RF Pacemakers Equipped With Wireless Technology
St. Jude Medical, Inc. (NYSE:STJ) announced European CE Mark approval of its Accent™ RF pacemaker and Anthem™ RF CRT-P (cardiac resynchronization therapy pacemaker). The Accent and Anthem product family features RF telemetry that enables secure, wireless communication between the implanted device...
St. Jude Medical Announces European CE Mark Approval And First Use Of Next-Generation Cardiac Mapping System
St. Jude Medical, Inc. (NYSE:STJ) announced European CE Mark approval and first use of its EnSite Velocity™ Cardiac Mapping System. This new system has been designed to help physicians more efficiently diagnose and deliver therapy to treat abnormal heart rhythms. St. Jude Medical will feature the EnSite...
ATS Medical Announces FDA Clearance Of The ATS Simulus Adjustable Annuloplasty Band
ATS Medical, Inc. (Nasdaq: ATSI), manufacturer and marketer of state-of-the-art cardiac surgery products and services, announced FDA clearance of the ATS Simulus(R) Adjustable Annuloplasty Band. The ATS Simulus Adjustable Annuloplasty Band is the next product in a portfolio of mitral valve repair products...
ATS Medical Announces FDA Clearance Of The ATS Simulus Adjustable Annuloplasty Band
ATS Medical, Inc. (Nasdaq: ATSI), manufacturer and marketer of state-of-the-art cardiac surgery products and services, announced FDA clearance of the ATS Simulus(R) Adjustable Annuloplasty Band. The ATS Simulus Adjustable Annuloplasty Band is the next product in a portfolio of mitral valve repair products...
St. Jude Medical Announces European Approval Of Its Newest Heart Failure Devices Which Enable More Efficient Implantation And Follow-up
St. Jude Medical, Inc. (NYSE:STJ) announced European CE Mark approval of its Promote Accel™ implantable cardiac resynchronization therapy defibrillator (CRT-D). The Promote Accel CRT-D automatically tailors treatment to individual patient needs by measuring the heart’s reaction to therapy and...
Study Examines Novel PFO Closure System
A new device designed to close a common heart defect known as a patent foramen ovale (PFO) is safe and effective at 90-days follow up, according to a new study released at the Society for Cardiovascular Angiography and Interventions (SCAI) 32nd Annual Scientific Sessions in Las Vegas. PFO is a common...
Trial Of Device That Reshapes Enlarged, Leaky Heart Valve Shows Intriguing Early Results
An innovative device that acts like a belt to reshape an enlarged, leaky heart valve is providing a minimally invasive treatment option for patients who are too sick for open-heart surgery. According to a Late-Breaking Clinical Trial presented at the Society for Cardiovascular Angiography and Interventions...